These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28085015)

  • 1. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
    Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
    BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of galectin-3 and E-cadherin expressions with lymph node metastasis of colon cancer].
    Wu ZH; Gan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1731-3. PubMed ID: 18024302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of signal transduction and activators of transcription 3, E-cadherin and vimentin in colon cancer].
    Zhang C; Xu JH; Liu T; Cui H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Mar; 14(3):202-5. PubMed ID: 21442485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
    Kolijn K; Verhoef EI; van Leenders GJ
    Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
    Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
    J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
    Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
    J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and roles of the epithelial mesenchymal transition markers E-cadherin and vimentin in hepatocellular carcinoma].
    Li YM; Han KQ; Zheng L; Li J; Xu SC; Tian YW; Li HY; Pi HF; Qian P; Liang P
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):279-84. PubMed ID: 24021790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition and clinicopathological correlation in craniopharyngioma.
    Qi ST; Zhou J; Pan J; Zhang C; Silky C; Yan XR
    Histopathology; 2012 Oct; 61(4):711-25. PubMed ID: 23551434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
    Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
    Zhou J; Tao D; Xu Q; Gao Z; Tang D
    Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
    Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
    Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer.
    Jie D; Zhongmin Z; Guoqing L; Sheng L; Yi Z; Jing W; Liang Z
    Dig Dis Sci; 2013 Jun; 58(6):1581-9. PubMed ID: 23314859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.
    Vos MC; Hollemans E; Ezendam N; Feijen H; Boll D; Pijlman B; van der Putten H; Klinkhamer P; van Kuppevelt TH; van der Wurff AA; Massuger LF
    J Ovarian Res; 2016 Sep; 9(1):53. PubMed ID: 27590006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.